ALGN
Price
$311.88
Change
+$11.06 (+3.68%)
Updated
Apr 23, 6:59 PM EST
One day until earnings call
XRAY
Price
$30.86
Change
+$0.49 (+1.61%)
Updated
Apr 23, 6:59 PM EST
9 days until earnings call
Ad is loading...

Compare predictions ALGN vs XRAY

Header iconALGN vs XRAY Comparison
Open Charts ALGN vs XRAYBanner chart's image
Align Technology
Price$311.88
Change+$11.06 (+3.68%)
Volume$244.39K
CapitalizationN/A
DENTSPLY SIRONA
Price$30.86
Change+$0.49 (+1.61%)
Volume$755.14K
CapitalizationN/A
View a ticker or compare two or three
ALGN vs XRAY Comparison Chart

Loading...

ALGNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
XRAYDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ALGN vs. XRAY commentary
Apr 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGN is a Hold and XRAY is a Hold.

COMPARISON
Comparison
Apr 24, 2024
Stock price -- (ALGN: $300.82 vs. XRAY: $30.37)
Brand notoriety: ALGN: Notable vs. XRAY: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ALGN: 80% vs. XRAY: 118%
Market capitalization -- ALGN: $24.63B vs. XRAY: $6.69B
ALGN [@Medical Specialties] is valued at $24.63B. XRAY’s [@Medical Specialties] market capitalization is $6.69B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.41B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGN’s FA Score shows that 0 FA rating(s) are green whileXRAY’s FA Score has 1 green FA rating(s).

  • ALGN’s FA Score: 0 green, 5 red.
  • XRAY’s FA Score: 1 green, 4 red.
According to our system of comparison, XRAY is a better buy in the long-term than ALGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGN’s TA Score shows that 3 TA indicator(s) are bullish while XRAY’s TA Score has 4 bullish TA indicator(s).

  • ALGN’s TA Score: 3 bullish, 7 bearish.
  • XRAY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, XRAY is a better buy in the short-term than ALGN.

Price Growth

ALGN (@Medical Specialties) experienced а -1.29% price change this week, while XRAY (@Medical Specialties) price change was -1.68% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.25%. For the same industry, the average monthly price growth was -3.04%, and the average quarterly price growth was +16.62%.

Reported Earning Dates

ALGN is expected to report earnings on Jul 24, 2024.

XRAY is expected to report earnings on Aug 01, 2024.

Industries' Descriptions

@Medical Specialties (+1.25% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for ALGN with price predictions.
OPEN
A.I.dvisor published
a Summary for XRAY with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ALGN($24.6B) has a higher market cap than XRAY($6.69B). ALGN has higher P/E ratio than XRAY: ALGN (55.01) vs XRAY (19.23). ALGN YTD gains are higher at: 9.788 vs. XRAY (-14.245). ALGN has higher annual earnings (EBITDA): 799M vs. XRAY (249M). ALGN has more cash in the bank: 973M vs. XRAY (334M). ALGN has less debt than XRAY: ALGN (127M) vs XRAY (2.3B). XRAY (3.97B) and ALGN (3.86B) have equivalent revenues.
ALGNXRAYALGN / XRAY
Capitalization24.6B6.69B368%
EBITDA799M249M321%
Gain YTD9.788-14.245-69%
P/E Ratio55.0119.23286%
Revenue3.86B3.97B97%
Total Cash973M334M291%
Total Debt127M2.3B6%
FUNDAMENTALS RATINGS
ALGN vs XRAY: Fundamental Ratings
ALGN
XRAY
OUTLOOK RATING
1..100
6250
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
7
Undervalued
PROFIT vs RISK RATING
1..100
93100
SMR RATING
1..100
6591
PRICE GROWTH RATING
1..100
5663
P/E GROWTH RATING
1..100
8585
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XRAY's Valuation (7) in the Medical Specialties industry is significantly better than the same rating for ALGN (79). This means that XRAY’s stock grew significantly faster than ALGN’s over the last 12 months.

ALGN's Profit vs Risk Rating (93) in the Medical Specialties industry is in the same range as XRAY (100). This means that ALGN’s stock grew similarly to XRAY’s over the last 12 months.

ALGN's SMR Rating (65) in the Medical Specialties industry is in the same range as XRAY (91). This means that ALGN’s stock grew similarly to XRAY’s over the last 12 months.

ALGN's Price Growth Rating (56) in the Medical Specialties industry is in the same range as XRAY (63). This means that ALGN’s stock grew similarly to XRAY’s over the last 12 months.

ALGN's P/E Growth Rating (85) in the Medical Specialties industry is in the same range as XRAY (85). This means that ALGN’s stock grew similarly to XRAY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALGNXRAY
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
60%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
58%
Momentum
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
63%
MACD
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
65%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
67%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
68%
Advances
ODDS (%)
Bullish Trend 27 days ago
76%
Bullish Trend 5 days ago
58%
Declines
ODDS (%)
Bearish Trend 9 days ago
69%
Bearish Trend 7 days ago
68%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
50%
Bullish Trend 2 days ago
56%
Aroon
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
76%
View a ticker or compare two or three
Ad is loading...
ALGNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
XRAYDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
LTCN40.934.39
+12.00%
Grayscale Litecoin TR LTC
KWEB26.561.05
+4.12%
KraneShares CSI China Internet ETF
ERET24.010.23
+0.98%
iShares Environmentally Aware Rl Est ETF
IIGD23.720.03
+0.12%
Invesco Investment Grade Defensive ETF
NANR55.68-0.28
-0.50%
SPDR S&P® North American Natural Res ETF

XRAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, XRAY has been loosely correlated with NVST. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if XRAY jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XRAY
1D Price
Change %
XRAY100%
-0.43%
NVST - XRAY
66%
Loosely correlated
+0.75%
WST - XRAY
51%
Loosely correlated
+0.89%
STAA - XRAY
50%
Loosely correlated
+0.34%
ALGN - XRAY
44%
Loosely correlated
+0.62%
GMED - XRAY
41%
Loosely correlated
+1.79%
More